Ryan D Kilpatrick

Author PubWeight™ 28.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005 3.75
2 Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006 2.89
3 Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005 2.47
4 Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005 2.16
5 Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension 2005 1.80
6 Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 2006 1.58
7 Trends in hip fracture rates in US hemodialysis patients, 1993-2010. Am J Kidney Dis 2013 1.54
8 Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol 2007 1.26
9 The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment. PLoS One 2011 1.23
10 Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients. J Am Soc Nephrol 2013 1.11
11 Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations. Am J Kidney Dis 2009 1.07
12 Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif 2005 1.00
13 CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis. Clin J Am Soc Nephrol 2013 0.95
14 Relationship between epoetin alfa dose and mortality: findings from a marginal structural model. Clin J Am Soc Nephrol 2009 0.85
15 Reverse epidemiology of blood pressure in dialysis patients. Kidney Int 2005 0.83
16 Racial differences in clinical use of cinacalcet in a large population of hemodialysis patients. Am J Nephrol 2013 0.82
17 A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls. Hemodial Int 2005 0.81
18 Confounding and control of confounding in nonexperimental studies of medications in patients with CKD. Adv Chronic Kidney Dis 2012 0.78
19 Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. Clin Cardiol 2013 0.78
20 Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. Am J Med Sci 2013 0.77
21 Optimal Use of Available Claims to Identify a Medicare Population Free of Coronary Heart Disease. Am J Epidemiol 2015 0.76
22 Association between hemoglobin level and cardiopulmonary performance in heart failure: insights from the HF-ACTION study. Int J Cardiol 2013 0.75